Outcome of Board Meeting held today

Profit growth above 25%EBITDA margin expansionNegative operating cash flowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-12.4%Reaction day

₹399.90

prior close

₹350.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-12.5% vs market

Pharmaceuticals peers, median of 147sector-0.1%-12.4% vs sector

On the reaction day the stock moved 12.5 pts less than Nifty Microcap 250 and 12.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.6

10m

-1.6

15m

-1.4

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-12.4+0.1-12.5-0.1-12.4

Next day

-12.5-0.2-12.3-0.2-12.3

-12.5+0.3-12.8-0.2-12.2

-12.0+0.9-12.8+0.0-12.0

-12.4+0.8-13.2+0.0-12.4

-13.2+2.2-15.4+0.6-13.9

-13.2+3.4-16.6+1.4-14.7

15d

-14.0-0.8-13.2-2.9-11.1

-12.7+2.9-15.7+0.3-13.0

-13.2+0.8-14.1-0.4-12.9

-20.7+0.0-20.7-3.2-17.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board of Directors approved audited standalone financial results for Q4 and FY ending March 31, 2025, along with a clean (unmodified) auditor opinion from Shah & Savla LLP. Full-year revenue from operations rose modestly to Rs. 28,586 lakhs (vs Rs. 28,158 lakhs last year), but the company reported a small loss of Rs. 40 lakhs in Q4. Profit after tax for the full year jumped nearly 3.3x to Rs. 711 lakhs from Rs. 216 lakhs, driven by margin expansion. However, operating cash flow swung to a negative Rs. 1,009 lakhs from a positive Rs. 941 lakhs last year, largely due to a sharp rise in inventories. The Board recommended a 10% dividend (Rs. 1.00 per share) with record date September 18, 2025 and AGM on September 25, 2025.

Likely market impact

Strong annual profit growth and a declared dividend are positives for shareholders, but the Q4 loss and weak operating cash flow signal working-capital stress; mixed signals likely lead to a neutral-to-cautious market reaction.